Nantahala Capital Management - ADC THERAPEUTICS SA ownership

ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 63 filers reported holding ADC THERAPEUTICS SA in Q4 2022. The put-call ratio across all filers is 1.49 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nantahala Capital Management ownership history of ADC THERAPEUTICS SA
ValueSharesWeighting
Q3 2023$230,674
-87.2%
257,162
-69.4%
0.02%
-88.6%
Q2 2023$1,806,000
+10.3%
840,0000.0%0.18%
+38.9%
Q1 2023$1,638,000
+75.3%
840,000
+245.3%
0.13%
+106.6%
Q4 2022$934,234243,2900.06%
Other shareholders
ADC THERAPEUTICS SA shareholders Q4 2022
NameSharesValueWeighting ↓
Vantage Consulting Group Inc 1,680,149$33,939,0009.12%
Redmile Group, LLC 7,451,029$150,511,0003.42%
Grosvenor Holdings, L.L.C. 1,517,212$30,648,0003.17%
Indie Asset Partners, LLC 96,582$1,951,0001.42%
MPM BioImpact LLC 337,396$6,815,0001.24%
Eventide Asset Management 1,975,000$39,895,0000.51%
HHLR ADVISORS, LTD. 500,000$10,100,0000.16%
Virtus ETF Advisers LLC 19,193$388,0000.15%
CNA FINANCIAL CORP 15,245$308,0000.08%
Employees Retirement System of Texas 278,000$5,616,0000.06%
View complete list of ADC THERAPEUTICS SA shareholders